Search Results
Sep 10, 2026, 13:12 ET Hims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS
Sept. 10, 2026 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC's sweeping federal complaint against the company in which the Commission accuses Hims of serious business misconduct.
More news about: Hagens Berman Sobol Shapiro LLP
Sep 10, 2026, 09:15 ET Inspiren Raises $70M Series C to Scale Physical AI for Senior Living
venture pedigree with flexible capital and operational impact. Its portfolio includes category-defining companies such as Databricks, Duolingo, Halter, Hims, Fin (formerly Intercom), Legora, Mercury, Plaid, Stord, and Verkada.
More news about: Inspiren
Sep 09, 2026, 17:20 ET Hims & Hers Health (HIMS) Investors with Substantial Losses Have Opportunity to Lead Hims & Hers Class Action Lawsuit Before November 2, 2026 Deadline
Sept. 9, 2026 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC's sweeping federal complaint against the company in which the Commission accuses Hims of serious business misconduct.
More news about: Hagens Berman Sobol Shapiro LLP
Sep 08, 2026, 13:15 ET Hims & Hers Health, Inc. (HIMS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Hims & Hers Health, Inc.
More news about: Glancy Prongay Wolke & Rotter LLP
Sep 07, 2026, 15:00 ET Hims & Hers Health, Inc. (HIMS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
opportunity to lead the securities fraud class action lawsuit against Hims & Hers Health, Inc. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN HIMS & HERS HEALTH, INC. (HIMS), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE NOVEMBER 2, 2026 (LEAD PLAINTIFF
More news about: Law Offices of Howard G. Smith
Sep 07, 2026, 13:50 ET Hims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS
Sept. 7, 2026 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC's sweeping federal complaint against the company in which the Commission accuses Hims of serious business misconduct.
More news about: Hagens Berman Sobol Shapiro LLP
Sep 06, 2026, 12:00 ET Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
bgandg.com/cases/hims-hers-health-inc-hims-class_action_lawsuit.Hims Case DetailsThe Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:Hims shared
More news about: Bronstein, Gewirtz & Grossman, LLC
Sep 05, 2026, 10:40 ET INVESTOR DEADLINE ALERT: Hims & Hers Health, Inc. (HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
firm, informs investors that a securities fraud class action lawsuit has been filed against Hims & Hers Health, Inc. (HIMS) (NYSE: HIMS) on behalf of those who purchased or acquired HIMS securities between August 4, 2025 and July 29, 2026, inclusive. The lawsuit is filed in the United States
More news about: Kessler Topaz Meltzer & Check, LLP
Sep 04, 2026, 22:00 ET Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS
Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS), if they purchased or otherwise acquired the Company's securities between August 4, 2025 and July 29, 2026, inclusive
More news about: ClaimsFiler
Sep 04, 2026, 12:20 ET Hims & Hers Health, Inc. (HIMS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
The Law Offices of Frank R. Cruz announces that investors with losses related to Hims & Hers Health, Inc. (HIMS) have opportunity to lead the securities fraud class action lawsuit.
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Sep 03, 2026, 15:14 ET Hims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS
Sept. 3, 2026 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC's sweeping federal complaint against the company in which the Commission accuses Hims of serious business misconduct.
More news about: Hagens Berman Sobol Shapiro LLP
Sep 03, 2026, 10:15 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Hims & Hers Health, Inc. - HIMS
Sept. 3, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Sep 03, 2026, 09:00 ET HIMS Investor Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Lawsuit Against Hims & Hers Health, Inc.
was filed on behalf of all persons and entities who purchased or otherwise acquired Hims & Hers Health, Inc. (NYSE: HIMS) securities between August 4, 2025 and July 29, 2026, inclusive (the "Class Period"). Hims operates a health and wellness platform that connects consumers to licensed healthcare
More news about: Robbins LLP
Sep 02, 2026, 19:40 ET HIMS INVESTOR ALERT: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead the Hims & Hers Class Action Lawsuit
acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between August 4, 2025 and July 29, 2026, inclusive (the "Class Period"), have until November 2, 2026 to seek appointment as lead plaintiff of the Hims & Hers class action lawsuit. Captioned Velanki v. Hims & Hers Health,
More news about: Robbins Geller Rudman & Dowd LLP
Sep 02, 2026, 15:44 ET HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit
"right for them;" (3) the foregoing conduct subjected Hims to regulatory scrutiny; (4) as a result of the foregoing, Hims was reasonably likely to incur fees and penalties; and (5) as a result of the foregoing, defendants' positive statements about Hims' business, operations, and prospects were materially
More news about: THE ROSEN LAW FIRM, P. A.
Sep 01, 2026, 08:03 ET AI Markets Are Mis-Pricing Capacity as Profit, New Constructs Warns
with huge datasets can save up to 80% in AI costs by using open-weight models: Hims CEO. Business Insider. businessinsider.com/hims-hers-ceo-andrew-dudum-datasets-ai-costs-open-weight-2026-8CNBC. (2026, August 18). Hims & Hers CEO Andrew Dudum on the company's approach to AI agents [Video].
More news about: New Constructs
Sep 01, 2026, 01:39 ET Cherubic Ventures Closes $68.88 Million Fund VI as AUM Surpasses $500 Million
It has invested in more than 200 companies globally, with early investments including Hims & Hers, Flexport, Calm,
More news about: Cherubic Ventures
Aug 27, 2026, 16:37 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Hims & Hers Health, Inc. - HIMS
Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Aug 26, 2026, 13:03 ET Hims & Hers Health (NYSE: HIMS) Stock Plunges 14% Following Major FTC Lawsuit Over Privacy & Billing; Hagens Berman Investigates Corporate Compliance and Investor Ramifications
(representing California)—filed a sweeping federal complaint against Hims & Hers in the U.S. District Court for the Northern District of California (FTC et al. v. Hims & Hers Health, Inc.).The market reaction was immediate. HIMS shares fell $4.32, or 14.73%, to close at $25.00 per
More news about: Hagens Berman Sobol Shapiro LLP
Aug 25, 2026, 10:31 ET Postpartum Depression Market to Evolve During the Forecast Period (2026-2036) with Breakthrough Treatments and Expanding Pipeline Assets | DelveInsight
Biogen Inc., Sage Therapeutics, Inc., Therapy Mama., Canopie., Postpartum Support International, SonderMind Inc., Maven Clinic Co., Wildflower Health, Hims & Hers Health, Inc., Medela, Bausch Health Companies Inc., Maternal Mental Health Alliance, MumsAid, Cedars-Sinai, Marinus Pharmaceuticals, Brii
More news about: DelveInsight Business Research, LLP
Aug 24, 2026, 11:05 ET HIMS INVESTIGATION NOTICE: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm
who purchased Hims & Hers Health, Inc. (NYSE: HIMS) securities and experienced losses may have legal rights under the federal securities laws.CONTACT KTMC TO DISCUSS YOUR LEGAL RIGHTS:If you purchased or acquired Hims & Hers Health, Inc. (NYSE: HIMS) securities and
More news about: Kessler Topaz Meltzer & Check, LLP
Aug 19, 2026, 16:19 ET Hims & Hers Health (NYSE: HIMS) Stock Plunges 14% Following Major FTC Lawsuit Over Privacy & Billing; Hagens Berman Investigates Corporate Compliance and Investor Ramifications
(representing California)—filed a sweeping federal complaint against Hims & Hers in the U.S. District Court for the Northern District of California (FTC et al. v. Hims & Hers Health, Inc.).The market reaction was immediate. HIMS shares fell $4.32, or 14.73%, to close at $25.00 per
More news about: Hagens Berman Sobol Shapiro LLP
Aug 18, 2026, 19:55 ET Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm
who purchased Hims & Hers Health, Inc. (NYSE: HIMS) securities and experienced losses may have legal rights under the federal securities laws.CONTACT KTMC TO DISCUSS YOUR LEGAL RIGHTS: If you purchased or acquired Hims & Hers Health, Inc. (NYSE: HIMS) securities and
More news about: Kessler Topaz Meltzer & Check, LLP
Aug 17, 2026, 08:55 ET Uniphore Launches Marketing AI to Usher in New Era: NYSE Content Update
Tuesday's session.Shares popped by 12.6% on Friday following the announcement.Opening BellHims & Hers (NYSE: HIMS) celebrates its 5th anniversary as a listed companyClosing BellSnowflake (NYSE: SNOW) celebrates
More news about: New York Stock Exchange
Aug 12, 2026, 15:02 ET NYSE: HIMS Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm
who purchased Hims & Hers Health, Inc. (NYSE: HIMS) securities and experienced losses may have legal rights under the federal securities laws.CONTACT KTMC TO DISCUSS YOUR LEGAL RIGHTS: If you purchased or acquired Hims & Hers Health, Inc. (NYSE: HIMS) securities and
More news about: Kessler Topaz Meltzer & Check, LLP